Live News EQUITY L impact May 26, 2026, 11:32 PM UTC

KalVista Pharmaceuticals Files SEC Form

KalVista Pharmaceuticals submits regulatory filing with the SEC. The filing is available for public review.

SQUAWKNEWS Updated May 26, 2026, 11:33 PM UTC

Filed: 2026-05-26 AccNo: 0001815308-26-000004 Size: 9 KB